| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
Healthcare Analytical Testing Services Market – Global Forecast To 2030
本レポートは、ヘルスケア分析検査サービス市場を、種類、エンドユーザー、地域別に分析しています。市場成長に影響を与える要因、市場における様々な機会と課題の分析、そして市場リーダーの競争環境の詳細を提供しています。さらに、マイクロマーケットを個々の成長傾向に基づいて分析し、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
The global healthcare analytical testing services market is projected to grow from USD 7.48 billion in 2025 to USD 12.48 billion by 2030, at a CAGR of 10.8% during the forecast period. The growing demand for quality assurance and compliance across industries, improvements in analytical techniques, and support from the government for investment and innovation are major factors anticipated to boost market growth. Additionally, the demand for customized testing solutions in new markets and the evolution in the regulatory environment are factors that contribute enormously to the increase in demand for analytical testing services.
世界のヘルスケア分析検査サービス市場は、2025年の74億8,000万米ドルから2030年には124億8,000万米ドルに拡大し、予測期間中は年平均成長率（CAGR）10.8%で成長すると予測されています。業界全体における品質保証とコンプライアンスへの需要の高まり、分析技術の向上、そして政府による投資とイノベーションへの支援は、市場の成長を後押しする主な要因として期待されています。さらに、新規市場におけるカスタマイズされた検査ソリューションの需要と規制環境の変化も、分析検査サービスの需要増加に大きく貢献しています。
The prominent players in the healthcare analytical testing services market are Eurofins Scientific SE (Luxembourg), LabCorp Holdings Inc. (US), WuXi AppTec (China), Charles River Laboratories (US), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Medpace Holdings, Inc. (US), Sartorius AG (Germany), Intertek Group Plc (UK), Merck KGaA (Germany), SourceBio International Limited (UK), ICON Plc (Ireland), ALS (Australia), Frontage Labs (US), STERIS Plc (US), IQVIA (US), Element Materials Technology (UK), Pace Analytical Services (US), Almac Group (UK), and Pharmaron Beijing Co., Ltd. (China), among others.
healthcare-analytical-testing-services-market-Ecosystem
Reasons to Buy the Report
The report will help both established companies and newcomers/smaller businesses understand the market dynamics, enabling them to increase their market share. Companies that purchase the report can use one or a combination of the strategies listed below to enhance their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (stringent regulatory guidelines, growing focus on analytical testing of biologics & biosimilars, increasing outsourcing of analytical testing by pharmaceutical & medical device companies, increasing number of clinical trials, growing R&D expenditure in pharmaceutical & biopharmaceutical industry, and rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing), restraints (increasing pressure on market players due to rising costs and market competition), opportunities (adoption of new techniques and technologies and growing focus on emerging economies), and challenges (shortage of skilled professionals, specific requirements for innovative formulations and medical devices, and need to improve sensitivity of bioanalytical methods) influencing the growth of the healthcare analytical testing services market.
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the healthcare analytical testing services market.
- Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the healthcare analytical testing services market.
- Market Development: Comprehensive information on lucrative emerging regions.
- Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the healthcare analytical testing services market.
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.